Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

  1. Herzog, T.J.
  2. Wahab, S.A.
  3. Mirza, M.R.
  4. Pothuri, B.
  5. Vergote, I.
  6. Graybill, W.S.
  7. Malinowska, I.A.
  8. York, W.
  9. Hurteau, J.A.
  10. Gupta, D.
  11. González-Martin, A.
  12. Monk, B.J.
Revista:
International Journal of Gynecological Cancer

ISSN: 1525-1438,  1048-891X

Ano de publicación: 2023

Volume: 33

Número: 11

Páxinas: 1733-1742

Tipo: Artigo

DOI: 10.1136/IJGC-2023-004605 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus